West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 332.77 USD 0.97%
Market Cap: 24.1B USD
Have any thoughts about
West Pharmaceutical Services Inc?
Write Note

West Pharmaceutical Services Inc
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

West Pharmaceutical Services Inc
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
West Pharmaceutical Services Inc
NYSE:WST
Deferred Income Tax
$9.4m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
-6%
Thermo Fisher Scientific Inc
NYSE:TMO
Deferred Income Tax
$1.1B
CAGR 3-Years
-8%
CAGR 5-Years
-11%
CAGR 10-Years
-11%
Danaher Corp
NYSE:DHR
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mettler-Toledo International Inc
NYSE:MTD
Deferred Income Tax
$107.7m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Deferred Income Tax
$128m
CAGR 3-Years
-24%
CAGR 5-Years
-28%
CAGR 10-Years
17%
No Stocks Found

West Pharmaceutical Services Inc
Glance View

Market Cap
24.1B USD
Industry
Life Sciences Tools & Services
Economic Moat
Narrow

Nestled in the heart of the pharmaceutical and healthcare industry is West Pharmaceutical Services Inc., a company that has woven itself into the fabric of drug delivery systems since its founding in 1923. This company, headquartered in Exton, Pennsylvania, operates with the precision of a Swiss watch, designing and manufacturing an array of cutting-edge containment and delivery solutions for injectable medicines. West's expertise is reflected in the products it develops—ranging from stoppers and seals for vials to advanced syringe and device technologies. Its robust research and development pipeline underscores a commitment to innovation, ensuring that new advances in drug delivery provide critical safety and efficacy for patients and healthcare professionals alike. West Pharmaceutical's business model revolves around partnering closely with pharmaceutical and biotechnology companies worldwide. This symbiotic relationship secures West's place at the forefront of global healthcare evolution. While the client companies focus on the complex process of drug formulation and therapeutic efficacy, West ensures that these drugs are delivered effectively and safely through its meticulously engineered components and systems. As a result, the company garners a revenue stream from a robust portfolio of products and services that cater to the long-term needs of its clients, helping them efficiently navigate the stringent regulatory environment. Through these partnerships and their resultant dividends, West Pharmaceutical Services continues to embed its name into the essential infrastructure of global health care.

WST Intrinsic Value
223.21 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is West Pharmaceutical Services Inc's Deferred Income Tax?
Deferred Income Tax
9.4m USD

Based on the financial report for Sep 30, 2024, West Pharmaceutical Services Inc's Deferred Income Tax amounts to 9.4m USD.

What is West Pharmaceutical Services Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-6%

Over the last year, the Deferred Income Tax growth was -43%. The average annual Deferred Income Tax growth rates for West Pharmaceutical Services Inc have been -7% over the past three years , -2% over the past five years , and -6% over the past ten years .

Back to Top